HIGH
Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect
HIGH
Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
Quick Facts at a Glance
- Recall Date
- September 29, 2025
- Hazard Level
- HIGH
- Brand
- Acuity Specialty Products
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
Hazard Information
cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Acuity Specialty Products, Inc. or your healthcare provider for guidance. Notification method: Letter
Product Details
The recall includes Wyandotte Sanifect E3 hand sanitizer (Ethanol-Based, Product 5511) with ethyl alcohol 60.1%. It was sold in package configurations of 6x1000mL cases, 4x1 gallon cases, 5-gallon pails, and 55-gallon drums.
The Hazard
The recall was initiated due to cGMP deviations. Required testing of incoming alcohol components was not performed, which raises the risk of methanol contamination.
Reported Incidents
No injuries or incidents have been reported related to this recall. Methanol exposure can lead to serious health issues.
What to Do
Stop using the product immediately. Consumers should contact Acuity Specialty Products or their healthcare provider for guidance.
Contact Information
For more information, call Acuity Specialty Products at 800-345-1329 or visit their website at [FDA Recall Notice](https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0004-2026).
Key Facts
- Recall initiated on September 29, 2025
- Potential risk of methanol contamination
- Sold nationwide in various package sizes
- Consumers advised to stop use immediately
Get Alerts for Health & Personal Care Recalls
Get notified about recalls in categories you care about.
Safety Assessment
Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER
Product Classification
Product TypeHand Sanitizer
Sold At
Multiple Retailers
Product Details
Model Numbers
Lot # C2427010
Exp 9/26/2025
Lot # C2432621
Exp 11/21/2025
Lot # C2501514
+3 more
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE
Related Recalls
HIGH
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
SUCRALFATE
CGMP Deviations:
HIGH
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect